Leila J Williams

4PUBLICATIONS
18CO-AUTHORS
Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 19, 2022
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.

Andrew Fedoriw, Leilei Shi, Shane O'Brien

|Dec 28, 2020
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies.

Sruthy Varghese, Snigdha Pramanik, Leila J Williams

|Sep 27, 2018
RNA editing derived epitopes function as cancer antigens to elicit immune responses.

Minying Zhang, Jens Fritsche, Jason Roszik

|Mar 03, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.

Lu Huang, Shruti Malu, Jodi A McKenzie

Pageof 1